# Purchase Order #75N98026P01683

Clinical Genetic Testing Services Awarded to University of Chicago Medical Center

**Buyer:** National Institutes of Health

**Award Amount:** $45,000.00
**Ceiling:** $225,000.00

**Awarded:** September 28, 2026
**Period of Performance:** Sep 28, 2026 - Sep 27, 2027

**Identifier:** 75N98026P01683
**NAICS:** 622110

This contract represents a purchase order awarded to The University of Chicago Medical Center, a leading academic medical institution known for advanced clinical research and patient care. The contract procures specialized genetic testing and next-generation sequencing services tailored for active clinical protocols focusing on bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders. The significance of this award lies in its support for critical clinical research and patient diagnostics within the Bethesda, Maryland area, enhancing understanding and treatment strategies in hematology. The scope includes performing comprehensive genetic analyses to support clinical protocols addressing these complex disorders. This award was obtained through a contracting process suitable for clinical and research-focused services, emphasizing expertise and capability. Initiated recently, the contract covers a one-year fixed performance period with options extending to a potential multi-year timeframe, allowing for sustained contributions to clinical research. No information was provided regarding contract vehicles, subcontractors, or previous related contracts.

### Description

EO 14398:  CLINICAL DIVISION GENETIC TESTING AND NEXT GENERATION SEQUENCING SERVICES FOR ACTIVE CLINICAL PROTOCOLS- BONE MARROW FAILURE SYNDROMES, APLASTIC ANEMIA, MYELOID NEOPLASMS, CLONAL HEMATOPOIESIS, AND RELATED HEMATOLOGIC DISORDERS.

[View original record](https://www.usaspending.gov/award/CONT_AWD_75N98026P01683_7529_-NONE-_-NONE-)